Page 179 - IJB-10-6

International Journal of Bioprinting 3D bioprinting technology for brain tumor

doi: 10.1016/j.yjmcc.2021.06.002 doi: 10.1242/jcs.248237
100. Pollet A, den Toonder JMJ. Recapitulating the vasculature 112. Greene C, Campbell M. Tight junction modulation of the
using organ-on-chip technology. Bioengineering (Basel). blood brain barrier: CNS delivery of small molecules. Tissue
2020;7(1):17. Barriers. 2016;4(1):e1138017.
doi: 10.3390/bioengineering7010017 doi: 10.1080/21688370.2015.1138017
101. Farhang Doost N, Srivastava SK. A comprehensive review of 113. Yang JY, Shin D-S, Jeong M, et al. Evaluation of drug
organ-on-a-chip technology and its applications. Biosensors. blood-brain-barrier permeability using a microfluidic chip.
2024;14(5):225. Pharmaceutics. 2024;16(5):574.
doi: 10.3390/bios14050225 doi: 10.3390/pharmaceutics16050574
102. Kumar V, Varghese S. Ex vivo tumor‐on‐a‐chip platforms 114. Chittiboyina S, Rahimi R, Atrian F, Ochoa M, Ziaie B,
to study intercellular interactions within the tumor Lelievre SA. Gradient-on-a-chip with reactive oxygen
microenvironment. Adv Healthc Mater. 2019;8(4): species reveals thresholds in the nucleus response of cancer
1801198. cells depending on the matrix environment. ACS Biomater
doi: 10.1002/adhm.201801198 Sci Eng. 2018;4(2):432-445.
doi: 10.1021/acsbiomaterials.7b00087
103. Fetah K, Tebon P, Goudie MJ, et al. The emergence of 3D
bioprinting in organ-on-chip systems. Prog Biomed Eng. 115. Sontheimer-Phelps A, Hassell BA, Ingber DE. Modelling
2019;1(1):012001. cancer in microfluidic human organs-on-chips. Nat Rev
doi: 10.1088/2516-1091/ab23df Cancer. 2019;19(2):65-81.
doi: 10.1038/s41568-018-0104-6
104. Gao Q, Liu Z, Lin Z, et al. 3D bioprinting of vessel-like
structures with multilevel fluidic channels. ACS Biomater 116. Malik A, Pal R, Gupta SK. EGF-mediated reduced miR-92a-
Sci Eng. 2017;3(3):399-408. 1-5p controls HTR-8/SVneo cell invasion through activation
doi: 10.1021/acsbiomaterials.6b00643 of MAPK8 and FAS which in turn increase MMP-2/-9
expression. Sci Rep. 2020;10(1):12274.
105. Samadian H, Jafari S, Sepand M, et al. 3D bioprinting
technology to mimic the tumor microenvironment: tumor- doi: 10.1038/s41598-020-68966-4
on-a-chip concept. Mater Today Adv. 2021;12:100160. 117. Liu D, Yang T, Ma W, Wang Y. Clinical strategies to
doi: 10.1016/j.mtadv.2021.100160 manage adult glioblastoma patients without MGMT
106. Alves AH, Nucci MP, Mamani JB, et al. The advances in hypermethylation. J Cancer. 2022;13(1):354.
glioblastoma on-a-chip for therapy approaches. Cancers. doi: 10.7150/jca.63595
2022;14(4):869. 118. Qu S, Qi S, Zhang H, et al. Albumin-bound paclitaxel
doi: 10.3390/cancers14040869
augment temozolomide treatment sensitivity of glioblastoma
107. Song Q, Sun J, Mu Y, Xu Y, Zhu Q, Jin Q. A new method cells by disrupting DNA damage repair and promoting
for polydimethylsiloxane (PDMS) microfluidic chips to ferroptosis. J Exp Clin Cancer Res. 2023;42(1):285.
maintain vacuum-driven power using Parylene C. Sens doi: 10.1186/s13046-023-02843-6
Actuators B: Chem. 2018;256:1122-1130. 119. Tsai C-Y, Ko H-J, Huang C-YF, et al. Ionizing radiation
doi: 10.1016/j.snb.2017.10.006
induces resistant glioblastoma stem-like cells by
108. Tabatabaei Rezaei N, Kumar H, Liu H, Lee SS, Park SS, promoting autophagy via the Wnt/β-catenin pathway. Life.
Kim K. Recent advances in organ-on-chips integrated with 2021;11(5):451.
bioprinting technologies for drug screening. Adv Healthc doi: 10.3390/life11050451
Mater. 2023;12(20):e2203172. 120. Yu W, Zhang L, Wei Q, Shao A. O6-methylguanine-
doi: 10.1002/adhm.202203172
DNA methyltransferase (MGMT): challenges and new
109. Nie J, Gao Q, Fu J, He Y. Grafting of 3D bioprinting to opportunities in glioma chemotherapy. Front Oncol.
in vitro drug screening: a review. Adv Healthc Mater. 2020;9:1547.
2020;9(7):e1901773. doi: 10.3389/fonc.2019.01547
doi: 10.1002/adhm.201901773
121. Kohutova A, Munzova D, Pesl M, Rotrekl V. alpha(1)-
110. Radhakrishnan J, Varadaraj S, Dash SK, Sharma A, Verma Adrenoceptor agonist methoxamine inhibits base excision
RS. Organotypic cancer tissue models for drug screening: repair via inhibition of apurinic/apyrimidinic endonuclease
3D constructs, bioprinting and microfluidic chips. Drug 1 (APE1). Acta Pharm. 2023;73(2):281-291.
Discov Today. 2020;25(5):879-890. doi: 10.2478/acph-2023-0012
doi: 10.1016/j.drudis.2020.03.002
122. Burman P, Lamb L, McCormack A. Temozolomide therapy
111. Yang Z, Wu S, Fontana F, et al. The tight junction protein for aggressive pituitary tumours–current understanding
Claudin-5 limits endothelial cell motility. J Cell Sci. and future perspectives. Rev Endocr Metab Disord.
2021;134(1):jcs248237. 2020;21:263-276.

Volume 10 Issue 6 (2024) 171 doi: 10.36922/ijb.4166